Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

M. K. de Vries; E. Brouwer; I. E. van der Horst-Bruinsma; A. Spoorenberg; J. C. van Denderen; A. Jamnitski; M. T. Nurmohamed; B. A. C. Dijkmans; L. A. Aarden; G. J. Wolbink

doi:10.1136/ard.2009.109702

Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

M. K. de Vries, E. Brouwer, I. E. van der Horst-Bruinsma^*, A. Spoorenberg, J. C. van Denderen, A. Jamnitski, M. T. Nurmohamed, B. A. C. Dijkmans, L. A. Aarden, G. J. Wolbink

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

87 Citations (Scopus)

Original language	English
Pages (from-to)	1787-1788
Number of pages	2
Journal	Annals of the Rheumatic Diseases
Volume	68
Issue number	11
DOIs	https://doi.org/10.1136/ard.2009.109702
Publication status	Published - Nov-2009

Keywords

ASAS CONSENSUS STATEMENT
RHEUMATOID-ARTHRITIS
IMMUNOGENICITY
INFLIXIMAB
EFFICACY
AGENTS

Access to Document

10.1136/ard.2009.109702

Handle.net

Persistent link

Cite this

de Vries, M. K., Brouwer, E., van der Horst-Bruinsma, I. E., Spoorenberg, A., van Denderen, J. C., Jamnitski, A., Nurmohamed, M. T., Dijkmans, B. A. C., Aarden, L. A., & Wolbink, G. J. (2009). Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation. Annals of the Rheumatic Diseases, 68(11), 1787-1788. https://doi.org/10.1136/ard.2009.109702

@article{f53059d5980c4659b3472c95b48fdbd6,

title = "Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation",

keywords = "ASAS CONSENSUS STATEMENT, RHEUMATOID-ARTHRITIS, IMMUNOGENICITY, INFLIXIMAB, EFFICACY, AGENTS",

author = "{de Vries}, {M. K.} and E. Brouwer and {van der Horst-Bruinsma}, {I. E.} and A. Spoorenberg and {van Denderen}, {J. C.} and A. Jamnitski and Nurmohamed, {M. T.} and Dijkmans, {B. A. C.} and Aarden, {L. A.} and Wolbink, {G. J.}",

year = "2009",

month = nov,

doi = "10.1136/ard.2009.109702",

language = "English",

volume = "68",

pages = "1787--1788",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ PUBLISHING GROUP",

number = "11",

}

de Vries, MK, Brouwer, E, van der Horst-Bruinsma, IE, Spoorenberg, A, van Denderen, JC, Jamnitski, A, Nurmohamed, MT, Dijkmans, BAC, Aarden, LA & Wolbink, GJ 2009, 'Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation', Annals of the Rheumatic Diseases, vol. 68, no. 11, pp. 1787-1788. https://doi.org/10.1136/ard.2009.109702

TY - JOUR

T1 - Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

AU - de Vries, M. K.

AU - Brouwer, E.

AU - van der Horst-Bruinsma, I. E.

AU - Spoorenberg, A.

AU - van Denderen, J. C.

AU - Jamnitski, A.

AU - Nurmohamed, M. T.

AU - Dijkmans, B. A. C.

AU - Aarden, L. A.

AU - Wolbink, G. J.

PY - 2009/11

Y1 - 2009/11

KW - ASAS CONSENSUS STATEMENT

KW - RHEUMATOID-ARTHRITIS

KW - IMMUNOGENICITY

KW - INFLIXIMAB

KW - EFFICACY

KW - AGENTS

U2 - 10.1136/ard.2009.109702

DO - 10.1136/ard.2009.109702

M3 - Editorial

SN - 0003-4967

VL - 68

SP - 1787

EP - 1788

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 11

ER -